Alexandra Litvinenko: ESR-12

Institution: UNIGE

Nationality: Russian

Post no.

ESR 12 CH1


36 months (Starting Date October 2015)

Work package

WP2, D2.CH1 (or D2.CH2?): Development and investigation of bimodal imaging probes for ovarian cancer in animal models

Recruiting partner

HUG, Switzerland

Type of Position

Early Stage Researcher/PhD positions

A mobility rule applies to this position. The respective candidate must not have worked for more than 12 months in Switzerland within the last three years. Furthermore, the candidate needs to be in his/her first four years of his/her research career. The four years are counted from the date a degree was obtained which formally entitles to embark on a doctorate. 

Short Description

The ESR will be in charge of participating in the development of radiolabelled imaging tracers as part of a joint project with EPFL for bifunctional fluorescent and radioactive ligand for ovarian cancer. The ESR will participate in the development of methodology and validation of preclinical techniques. He/she will be responsible of seeking new methodological techniques and animal experimental imaging protocols that are suitable for the new compounds that are being evaluated. The work will be performed at the University hospital of Geneva and the Institute of Translational Molecular Imaging (ITMI).

Expertise in chemical sciences with strong motivation to be involved in the study of metal–based compounds for biomedical applications. The candidate would ideally have experience in organic/inorganic chemistry. Furthermore, candidates that have some experience (or at least a strong interest) in radiochemistry and/or cell biology will be favoured

According to the Marie Sklodowska-Curie ITN rules: about 4200 CHF/month including mobility allowance or 4700CHF/month including mobility and family allowance (registered partner and/or child).

Enrolment for PhD at

University of Geneva, Switzerland


Prof. Osman Ratib

Tel: + 41 22 3727145

Planned secondment(s)

Instituto Superior Técnico Lisbon, Portugal – 3 months – Assessment of radiolabelled probes for brachytherapy in small animals

TRIUMF, Canada – 3 months – Development of bimodal imaging probes